COMPOSITIONS FOR INHIBITING PLATELET AGGREGATION

THE INVENTION IS A PHARMACEUTICAL COMPOSITION FOR INTRAVENOUS ADMINISTRATION TO A PATIENT COMPRISING A)A PHARMACEUTICALLY EFFECTIVE AMOUNT OF A COMPOUND HAVING THE FORMULA ( FORMULA 1 ) 2-S-(N-BUTYlSULFONYLAMINO)-3-[4-(4-PIPERIDIN-4-YL)BUTYLOXY)PHENYL] PROPIONIC ACID; B)A PHARMACEUTICALLY ACCEPTABLE...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: KARL M. GELOTTE
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator KARL M. GELOTTE
description THE INVENTION IS A PHARMACEUTICAL COMPOSITION FOR INTRAVENOUS ADMINISTRATION TO A PATIENT COMPRISING A)A PHARMACEUTICALLY EFFECTIVE AMOUNT OF A COMPOUND HAVING THE FORMULA ( FORMULA 1 ) 2-S-(N-BUTYlSULFONYLAMINO)-3-[4-(4-PIPERIDIN-4-YL)BUTYLOXY)PHENYL] PROPIONIC ACID; B)A PHARMACEUTICALLY ACCEPTABLE AMOUNT OF A CITRATE BUFFER EFFECTIVE TO PROVIDE A PH OF BETWEEN ABOUT 5 AND 7; AND C)A PHARMACEUTICALLY ACCEPTABLE AMOUNT OF A TONICITY ADJUSTING AGENT EFFECTIVE TO MAKE THE FORMULATION SUBSTANTIALLY ISOTONIC WITH THE OSMOTIC PRESSURE OF THE BIOLOGICAL SYSTEM OF THE PATIENT.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_MY116837A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>MY116837A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_MY116837A3</originalsourceid><addsrcrecordid>eNrjZDBw9vcN8A_2DPH09wtWcPMPUvD08_B0AvL93BUCfBxDXH1cQxQc3d2DXN0dQYp4GFjTEnOKU3mhNDeDnJtriLOHbmpBfnxqcUFicmpeakm8b6ShoZmFsbmjMUEFAHhrJYU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>COMPOSITIONS FOR INHIBITING PLATELET AGGREGATION</title><source>esp@cenet</source><creator>KARL M. GELOTTE</creator><creatorcontrib>KARL M. GELOTTE</creatorcontrib><description>THE INVENTION IS A PHARMACEUTICAL COMPOSITION FOR INTRAVENOUS ADMINISTRATION TO A PATIENT COMPRISING A)A PHARMACEUTICALLY EFFECTIVE AMOUNT OF A COMPOUND HAVING THE FORMULA ( FORMULA 1 ) 2-S-(N-BUTYlSULFONYLAMINO)-3-[4-(4-PIPERIDIN-4-YL)BUTYLOXY)PHENYL] PROPIONIC ACID; B)A PHARMACEUTICALLY ACCEPTABLE AMOUNT OF A CITRATE BUFFER EFFECTIVE TO PROVIDE A PH OF BETWEEN ABOUT 5 AND 7; AND C)A PHARMACEUTICALLY ACCEPTABLE AMOUNT OF A TONICITY ADJUSTING AGENT EFFECTIVE TO MAKE THE FORMULATION SUBSTANTIALLY ISOTONIC WITH THE OSMOTIC PRESSURE OF THE BIOLOGICAL SYSTEM OF THE PATIENT.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2004</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20040430&amp;DB=EPODOC&amp;CC=MY&amp;NR=116837A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25562,76317</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20040430&amp;DB=EPODOC&amp;CC=MY&amp;NR=116837A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KARL M. GELOTTE</creatorcontrib><title>COMPOSITIONS FOR INHIBITING PLATELET AGGREGATION</title><description>THE INVENTION IS A PHARMACEUTICAL COMPOSITION FOR INTRAVENOUS ADMINISTRATION TO A PATIENT COMPRISING A)A PHARMACEUTICALLY EFFECTIVE AMOUNT OF A COMPOUND HAVING THE FORMULA ( FORMULA 1 ) 2-S-(N-BUTYlSULFONYLAMINO)-3-[4-(4-PIPERIDIN-4-YL)BUTYLOXY)PHENYL] PROPIONIC ACID; B)A PHARMACEUTICALLY ACCEPTABLE AMOUNT OF A CITRATE BUFFER EFFECTIVE TO PROVIDE A PH OF BETWEEN ABOUT 5 AND 7; AND C)A PHARMACEUTICALLY ACCEPTABLE AMOUNT OF A TONICITY ADJUSTING AGENT EFFECTIVE TO MAKE THE FORMULATION SUBSTANTIALLY ISOTONIC WITH THE OSMOTIC PRESSURE OF THE BIOLOGICAL SYSTEM OF THE PATIENT.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2004</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDBw9vcN8A_2DPH09wtWcPMPUvD08_B0AvL93BUCfBxDXH1cQxQc3d2DXN0dQYp4GFjTEnOKU3mhNDeDnJtriLOHbmpBfnxqcUFicmpeakm8b6ShoZmFsbmjMUEFAHhrJYU</recordid><startdate>20040430</startdate><enddate>20040430</enddate><creator>KARL M. GELOTTE</creator><scope>EVB</scope></search><sort><creationdate>20040430</creationdate><title>COMPOSITIONS FOR INHIBITING PLATELET AGGREGATION</title><author>KARL M. GELOTTE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_MY116837A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2004</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>KARL M. GELOTTE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KARL M. GELOTTE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>COMPOSITIONS FOR INHIBITING PLATELET AGGREGATION</title><date>2004-04-30</date><risdate>2004</risdate><abstract>THE INVENTION IS A PHARMACEUTICAL COMPOSITION FOR INTRAVENOUS ADMINISTRATION TO A PATIENT COMPRISING A)A PHARMACEUTICALLY EFFECTIVE AMOUNT OF A COMPOUND HAVING THE FORMULA ( FORMULA 1 ) 2-S-(N-BUTYlSULFONYLAMINO)-3-[4-(4-PIPERIDIN-4-YL)BUTYLOXY)PHENYL] PROPIONIC ACID; B)A PHARMACEUTICALLY ACCEPTABLE AMOUNT OF A CITRATE BUFFER EFFECTIVE TO PROVIDE A PH OF BETWEEN ABOUT 5 AND 7; AND C)A PHARMACEUTICALLY ACCEPTABLE AMOUNT OF A TONICITY ADJUSTING AGENT EFFECTIVE TO MAKE THE FORMULATION SUBSTANTIALLY ISOTONIC WITH THE OSMOTIC PRESSURE OF THE BIOLOGICAL SYSTEM OF THE PATIENT.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_MY116837A
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title COMPOSITIONS FOR INHIBITING PLATELET AGGREGATION
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T12%3A01%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KARL%20M.%20GELOTTE&rft.date=2004-04-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EMY116837A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true